Korean Circ J.  2014 Sep;44(5):344-347. 10.4070/kcj.2014.44.5.344.

Transcatheter Aortic Valve Implantation in a Patient with Previous Mitral Valve Replacement

Affiliations
  • 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. mkhong61@yuhs.ac
  • 2Department of Thoracic and Cardiovascular Surgery, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • 3Department of Anesthesiology and Pain Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

Abstract

Transcatheter aortic valve implantation (TAVI) has shown favorable outcomes in patients with severe symptomatic aortic valve stenosis who are at high surgical risk or are unsuitable candidates for open heart surgery. However, concerns exist over treating patients who have previously undergone mitral valve surgery due to the potential interference between the mitral prosthetic valve or ring and the TAVI device. In this case report, we present a patient with symptomatic severe aortic stenosis and previous mechanical mitral valve replacement who was successfully treated with TAVI using a CoreValve.

Keyword

Aortic valve stenosis; Catheters; Heart valve prosthesis; Prosthesis implantation; Mitral valve

MeSH Terms

Aortic Valve Stenosis
Aortic Valve*
Catheters
Heart Valve Prosthesis
Humans
Mitral Valve*
Prosthesis Implantation
Thoracic Surgery

Figure

  • Fig. 1 Pre-procedural transthoracic echocardiogram with a parasternal long axis view of the heavily calcified aortic valve with valve area of 0.41 cm2. A: without color Doppler. B: with color Doppler. AV: aortic valve, LA: left atrium, LV: left ventricle, RV: right ventricle, pMV: prosthetic mitral valve.

  • Fig. 2 Fluoroscopic images of transcatheter aortic valve implantation using a CoreValve. A: partially deployed CoreValve. B: completely deployed CoreValve. TEE: transesophageal echocardiography probe, pMV: bileaflet mechanical prosthetic mitral valve (dotted circle), W: superstiff wire inserted into the left ventricle, TP: temporary pacemaker inserted into the right ventricle.

  • Fig. 3 Post-procedural images of transesophageal echocardiography (135 degree long axis view). A: without color Doppler. B: with color Doppler. The implanted CoreValve (arrowheads) did not interfere with the mechanical mitral valve (white arrow). The black arrows indicate a mild degree of paravalvular leak. Ao: aorta, LA: left atrium, LV: left ventricle, pMV: prosthetic mitral valve.

  • Fig. 4 Pressure gradient over the aortic valve as measured by transthoracic echocardiography. A: before TAVI. B: after TAVI. Peak/mean pressure gradient was reduced from 54/30 mm Hg to 18/8 mm Hg. TAVI: transcatheter aortic valve implantation.


Reference

1. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006; 47:1214–1223.
2. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008; 1:167–175.
3. Kim IS, Ko YG, Shin S, et al. The first case of successful transcatheter aortic valve implantation using CoreValve in Korea. Korean Circ J. 2012; 42:788–791.
4. Akins CW, Buckley MJ, Daggett WM, et al. Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg. 1998; 65:1545–1551. discussion 1551-2.
5. Jamieson WR, Burr LH, Miyagishima RT, et al. Re-operation for bioprosthetic aortic structural failure - risk assessment. Eur J Cardiothorac Surg. 2003; 24:873–878.
6. Soon JL, Ye J, Lichtenstein SV, Wood D, Webb JG, Cheung A. Transapical transcatheter aortic valve implantation in the presence of a mitral prosthesis. J Am Coll Cardiol. 2011; 58:715–721.
7. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv. 2010; 3:359–366.
8. Antman EM. Implications of contemporary clinical trials series: the Placement of Aortic Transcatheter Valve trial (PARTNER). Circulation. 2012; 125:3054.
9. Rodés-Cabau J, Dumont E, Miró S, et al. Apical aortic valve implantation in a patient with a mechanical valve prosthesis in mitral position. Circ Cardiovasc Interv. 2008; 1:233.
10. Bruschi G, De Marco F, Oreglia J, et al. Percutaneous implantation of CoreValve aortic prostheses in patients with a mechanical mitral valve. Ann Thorac Surg. 2009; 88:e50–e52.
11. Bruschi G, De Marco F, Barosi A, et al. Self-expandable transcatheter aortic valve implantation for aortic stenosis after mitral valve surgery. Interact Cardiovasc Thorac Surg. 2013; 17:90–95.
Full Text Links
  • KCJ
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr